URT sp. z o.o.sp. k.
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2012-11-30
Limited partner contribution
27,000.00 PLN
Registered address
11 Listopada 24/-, 41-303 Dąbrowa Górnicza, Poland
Industry
Partners
| Partners | Partner role |
|---|---|
Jacek Marek Urantówkaage 74 | Limited partner |
Barbara Ewa Pieszczekage 41 | Limited partner |
Urt Sp. z o.o. | General partner |
Manner of representation
The right to represent the company in all judicial and extrajudicial matters is vested exclusively in the partner bearing unlimited liability, the general partner. The President of the Management Board is authorised to represent the company and to submit declarations of will on behalf of the general partner independently, while each other member of the management board is authorised to do so jointly with another member of the management board or a commercial proxy. The management board consists of the President of the Management Board – Jacek Urantówka.
Beneficial owners
No beneficial owners recorded for the company URT sp. z o.o..
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Wrocławskie Zakłady Zielarskie HerbapolS.A. | $46,537,868.51 | herbapol.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| STEM Cells SpinS.A. | $287,714.76 | stemcellsspin.com.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
FAQ
The company was registered in the Polish National Court Register (KRS) on November 30, 2012.
The headquarters is located at: 11 Listopada 24, 41-303 Dąbrowa Górnicza.
The share capital of the company is PLN 27,000 (approx. $7,293).
The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.
Last updated: 2026-03-24